Clinical trial
Trial of Ixazomib for Kaposi Sarcoma
NCT04305691
Study timeline
Study start (actual)2023-11-07Date precision: day
Registry last updated2026-02-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Kaposi Sarcomaunresolved
Skinunresolved
Interventions
Ixazomib CitrateDRUG · verified · RxNorm: ixazomib citrate
Sponsors & collaborators
AIDS Malignancy Consortiumlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
HoustonTexas, United States2New YorkNew York, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1MiamiFlorida, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1San DiegoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04305691 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.